Details of the Drug Reposition

General Information of This Drug (ID: DMKDGI8)

• Drug Name: BP-100-1-01 (DMKDGI8)

Information on Drug Reposition of This Drug

5 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic myelogenous leukaemia	DIS0301E	2A20.0	Phase 2	[1]
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 2	[1]
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 2	[1]
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 2	[1]
Hematologic tumour	DIS9Y1NR	2B33.Y	Phase 2	[1]

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032443)